Home › Funds › Werlinich Asset Management, LLC › DGX
Werlinich Asset Management, LLC position in DGX
QUEST DIAGNOSTICS INC · Health Care
Werlinich Asset Management, LLC reported holding 3,080 shares of DGX (QUEST DIAGNOSTICS INC) in its Q3 2026 13F filing — a position valued at US$718K, representing 0.28% of its reported portfolio and ranking #49 among its reported holdings. Werlinich Asset Management, LLC has disclosed DGX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR
How Werlinich Asset Management, LLC's DGX position evolved
Werlinich Asset Management, LLC first disclosed a stake in DGX in Q3 2023 at 7,154 shares (US$872K). The position peaked in Q4 2023 at 6,815 shares, worth US$938K. Across 13 filings, Werlinich Asset Management, LLC increased the stake 2 time(s), trimmed it 5 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 3,080 shares valued at US$718K. Notable position changes include a 43% trim in Q1 2024 (shares rose 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 7.15K | $871.84K | New |
| Q4 2023 | 6.82K | $937.61K | Reduce |
| Q1 2024 | 3.90K | $511.79K | Reduce |
| Q2 2024 | 3.75K | $515.71K | Reduce |
| Q3 2024 | 3.75K | $582.96K | Hold |
| Q4 2024 | 3.41K | $514.81K | Reduce |
| Q1 2025 | 3.41K | $576.97K | Hold |
| Q2 2025 | 2.91K | $522.72K | Reduce |
| Q3 2025 | 2.91K | $554.59K | Hold |
| Q4 2025 | 3.03K | $531.74K | Add |
| Q1 2026 | 3.08K | $603.62K | Add |
| Q2 2026 | 3.08K | $652.81K | Hold |
| Q3 2026 | 3.08K | $717.86K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DGX and 13F data
DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 31 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.00B), EdgePoint Investment Group Inc. (US$476.4M), Grantham, Mayo, Van Otterloo & Co. LLC (US$400.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DGX
- Boston Partners 4.74M sh · $1.00B · Q2 2026
- EdgePoint Investment Group Inc. 2.25M sh · $476.37M · Q2 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 1.89M sh · $400.21M · Q2 2026
- DAVIS SELECTED ADVISERS 1.56M sh · $329.78M · Q2 2026
- M&G Plc 795.65K sh · $168.68M · Q2 2026
More on Werlinich Asset Management, LLC
FAQ
How long has Werlinich Asset Management, LLC held DGX?
Werlinich Asset Management, LLC has disclosed DGX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Werlinich Asset Management, LLC's current position in DGX?
As of Q3 2026, Werlinich Asset Management, LLC holds 3.08K shares of DGX (QUEST DIAGNOSTICS INC), valued at $717.86K, representing 0.28% of its reported portfolio and ranking #49.
Has Werlinich Asset Management, LLC been buying or selling DGX?
In the latest 13F filing (Q3 2026), Werlinich Asset Management, LLC held unchanged its position in DGX. The position peaked in Q4 2023 at 6.82K shares.
Which other funds hold DGX?
Other major institutional holders of DGX include Boston Partners, EdgePoint Investment Group Inc., Grantham, Mayo, Van Otterloo & Co. LLC, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.